Back to top
more

ICU Medical (ICUI)

(Real Time Quote from BATS)

$97.08 USD

97.08
30,543

+2.24 (2.36%)

Updated Apr 29, 2024 11:30 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for ICUI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

ICU Medical, Inc. [ICUI]

Reports for Purchase

Showing records 261 - 280 ( 291 total )

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 261

08/29/2012

Company Report

Pages: 9

ICUI: Mgmt. Check In: Good Execution in 1H:12, Confidence With Base Business, New Products Could be Impactful Latest Hospira Warning Letter Should Not Impact ICU Medical

Provider: COLLIERS SECURITIES

Analyst: HUSAIN J

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 262

07/18/2012

Daily Note

Pages: 13

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 50.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 263

07/17/2012

Company Report

Pages: 6

2Q:12 - More Positives Than Negatives in the Quarter

Provider: COLLIERS SECURITIES

Analyst: HUSAIN J

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 264

07/17/2012

Company Report

Pages: 8

Good Quarter; More Margin, Less Growth This Year; Buy on Any Weakness

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 265

07/16/2012

Daily Note

Pages: 10

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 266

07/13/2012

Company Report

Pages: 5

2Q12 Preview: Could See Higher EPS;Consistent 2012 Outlook

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 267

06/28/2012

Industry Report

Pages: 3

Healthcare: Med Tech: The Vote Is In - ACA Upheld; Device Tax a Headwind into 2013

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 268

05/30/2012

Company Report

Pages: 12

Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 269

05/18/2012

Industry Report

Pages: 3

Med Tech Earnings Wrap-Up: What Looks Good Out of 1Q12

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 270

04/17/2012

Daily Note

Pages: 11

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 271

04/17/2012

Company Report

Pages: 7

Raising Target on Improved FY13 Earnings Outlook, Value; Maintain Buy

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 272

04/16/2012

Company Report

Pages: 7

ICUI: Good 1Q:12 Strong IV Therapy, Solid OUS Growth, and Pending New Products Keeps Us BUY Rated on ICU Medical

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 273

04/16/2012

Daily Note

Pages: 6

Healthcare: 1Q12 Medical Tech Earnings Preview

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 274

04/04/2012

Industry Report

Pages: 8

Healthcare - 1Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 275

02/29/2012

Industry Report

Pages: 3

C. K. COOPER HEALTHCARE DROPPING COVERAGE

Provider: C.K. Cooper and Company

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 276

02/08/2012

Company Report

Pages: 7

ICUI: Checking In With ICU Medical at the Society of Critical Care Medicines 41st Annual Congress

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 277

01/31/2012

Company Report

Pages: 6

ICUI: 4Q11: Slightly Soft on Top, Beat on Bottom 2012 Guidance and Weak Critical Care Business Might Disappoint

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 278

01/18/2012

Industry Report

Pages: 6

Medical Technology: We Believe Recent Pricing Pressures for Infusion Disposables Are Unique to CareFusion

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 279

01/05/2012

Company Report

Pages: 8

ICUI: Stable Growth for Must Need Medical Consumables Manufacturer Initiating Coverage of ICU Medical (ICUI) With a Buy Rating, PT $53

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 280

08/02/2011

Daily Note

Pages: 3

HEALTHCARE -- SUSPENDING COVERAGE : Due to analyst departure.

Provider: C.K. Cooper and Company

Analyst: COHEN J

Price: 10.00

Research Provided by a Third Party